HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting.

Abstract
Synthetic and molecularly defined constructs containing the minimal components to mimic and amplify the physiological immune response are able to induce an efficient cytotoxic response. In the current study this approach was applied to the development of highly versatile liposomal constructs to co-deliver peptide epitopes in combination with TLR agonists in order to induce a specific anti-tumor cellular immune response against ErbB2 protein-expressing tumor cells. Liposomes containing ErbB2 p63-71 cytotoxic T lymphocyte (CTL) and HA307-319 T- helper (Th) peptide epitopes associated to innovative synthetic TLR2/1 (Pam(3)CAG) or TLR2/6 agonists (Pam(2)CAG and Pam(2)CGD), were injected in mice bearing ErbB2 protein-expressing tumor cells. Mannosylated ligands were also incorporated into the constructs to target antigen-presenting cells. We showed that the TLR2/6 agonists were more efficient than the TLR2/1 agonists for the eradication of tumors expressing ErbB2 protein. Furthermore, mannose-targeted liposomes displayed higher therapeutic efficiency against tumor allowing treatment with decreased quantities of both TLR ligands and peptide epitopes. Our results validated that antigen-associated mannosylated liposomes combined with efficient TLR ligands are effective vectors for vaccination against tumor. In this study we developed useful tools to evaluate the vaccination efficiency of various adjuvants and/or targeting molecules and their potential synergy.
AuthorsJean-Sébastien Thomann, Béatrice Heurtault, Steffen Weidner, Mélanie Brayé, Julien Beyrath, Sylvie Fournel, Francis Schuber, Benoît Frisch
JournalBiomaterials (Biomaterials) Vol. 32 Issue 20 Pg. 4574-83 (Jul 2011) ISSN: 1878-5905 [Electronic] Netherlands
PMID21474175 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • Cancer Vaccines
  • Epitopes
  • Lectins, C-Type
  • Liposomes
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Peptides
  • Receptors, Cell Surface
  • Toll-Like Receptors
  • Receptor, ErbB-2
Topics
  • Adjuvants, Immunologic (chemistry)
  • Animals
  • Cancer Vaccines (therapeutic use)
  • Epitopes (immunology)
  • Female
  • Lectins, C-Type (immunology)
  • Liposomes (chemistry, immunology)
  • Mannose Receptor
  • Mannose-Binding Lectins (immunology)
  • Materials Testing
  • Mice
  • Mice, Inbred BALB C
  • Molecular Structure
  • Neoplasms (drug therapy, immunology, prevention & control)
  • Peptides (chemistry, immunology)
  • Receptor, ErbB-2 (immunology)
  • Receptors, Cell Surface (immunology)
  • Toll-Like Receptors (agonists, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: